Clinical trials
Phase 3 Constipation trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
87 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 1 |
| 2005 | 5 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 9 |
| 2009 | 6 |
| 2010 | 8 |
| 2011 | 5 |
| 2012 | 4 |
| 2013 | 7 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 58 |
| Terminated | 11 |
| Unknown status | 10 |
| Withdrawn | 3 |
| Not yet recruiting | 2 |
| Active, not recruiting | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 7 |
| Bausch Health Americas, Inc. | 6 |
| Movetis | 6 |
| Forest Laboratories | 4 |
| Kissei Pharmaceutical Co., Ltd. | 4 |
| Boehringer Ingelheim | 3 |
| Norgine | 3 |
| Novartis | 3 |
| Takeda | 3 |
| Braintree Laboratories | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Constipation | 87 |
| Opioid-Induced Constipation | 9 |
| Pain | 9 |
| Irritable Bowel Syndrome | 7 |
| Bronchiolitis Obliterans Syndrome | 6 |
| Dysmenorrhea | 4 |
| Dyspareunia | 4 |
| Endometriosis | 4 |
| Abdominal Pain | 3 |
| Dyspepsia | 3 |
Trials
Showing 51 to 75 of 87. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.